Assessment of Optimal Size and Composition of the U.S. National Registry of Hematopoietic Stem Cell Donors

Background. The National Marrow Donor Program (NMDP) receives federal funding to operate a registry of over 4 million volunteer donors for patients in need of a hematopoietic stem cell transplant. Because minority patients are less likely to find a suitably matched donor than whites, special efforts have been aimed toward recruitment of minorities. Significant financial resources are required to recruit and tissue type additional volunteer donors. Methods. Population genetics models have been constructed to project likelihoods of finding a human leukocyte antigen (HLA)-matched donor for patients of various racial/ethnic groups. These projections have been made under a variety of strategies for expansion of the NMDP Registry. Cost-effectiveness calculations incorporated donor unavailability and other barriers to transplantation. Results. At current recruitment rates, the probability of an available HLA-A,B,DRB1 matched donor is projected to increase from 27% to 34%; 45% to 54%; 75% to 79%; and 48% to 55%, for blacks, Asians/Pacific Islanders, whites and Hispanics, respectively, by the year 2007. Substantial increases in minority recruitment would have only modest impacts on these projections. These projections are heavily affected by donor availability rates, which are less than 50% for minority volunteers. Conclusions. Continued recruitment of additional volunteers can improve the likelihood of finding an HLA-matched donor, but will still leave significant numbers of patients of all racial/ethnic groups without a match. Efforts to improve donor availability (especially among minorities) and to increase the number of patients with access to the NMDP Registry may prove to be more cost-effective means of increasing transplants.

[1]  E. Zumwalt,et al.  The origins and development of the National Marrow Donor Program. , 1993, Leukemia.

[2]  J. Piliavin,et al.  On willingness to be a bone marrow donor , 1986, Transfusion.

[3]  D. Confer The National Marrow Donor Program , 2001, Cancer.

[4]  E. Milford,et al.  IMPACT OF RACIAL GENETIC POLYMORPHISM ON THE PROBABILITY OF FINDING AN HLA‐MATCHED DONOR , 1995, Transplantation.

[5]  J. Hansen,et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.

[6]  D. Confer Unrelated marrow donor registries , 1997, Current opinion in hematology.

[7]  R. Chakraborty,et al.  Is being Hispanic a risk factor for non-insulin dependent diabetes mellitus (NIDDM)? , 1999, Ethnicity & disease.

[8]  D. Monos,et al.  Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. , 2001, Tissue antigens.

[9]  C. Kollman,et al.  Non-HLA barriers to unrelated donor stem cell transplantation , 2001, Bone Marrow Transplantation.

[10]  A. Zander,et al.  Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. , 2001, Blood.

[11]  K. Boucher,et al.  HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. , 1997, Transplantation.

[12]  R Witzig,et al.  The Medicalization of Race: Scientific Legitimization of a Flawed Social Construct , 1996, Annals of Internal Medicine.

[13]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[14]  M. Pepe,et al.  Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. , 1991, Transplantation.

[15]  D. Monos,et al.  Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable. , 1993, Tissue antigens.

[16]  J. Long,et al.  An E-M algorithm and testing strategy for multiple-locus haplotypes. , 1995, American journal of human genetics.

[17]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[18]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[19]  E. Milford,et al.  Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  M. Dew,et al.  Factors associated with attrition from a national bone marrow registry , 1999, Bone Marrow Transplantation.

[21]  H. Inoko,et al.  The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. , 2002, Blood.

[22]  M. Dew,et al.  Helping Unrelated Strangers: Physical and Psychological Reactions to the Bone Marrow Donation Process Among Anonymous Donors1 , 1996 .

[23]  M. Dew,et al.  Understanding donors' motivations: a study of unrelated bone marrow donors. , 1997, Social science & medicine.

[24]  D. R. Yanke Recruiting unrelated donors for the National Marrow Donor Program. , 1990, The Yale journal of biology and medicine.

[25]  Anajane G. Smith,et al.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.

[26]  Recruiting unrelated donors for the National Marrow Donor Program. , 1990 .

[27]  N. Crowcroft,et al.  Race, ethnicity, culture, and science , 1994, BMJ.

[28]  K. Boucher,et al.  Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. , 2000, Human immunology.